09-Dec-2009 - Teva will continue to use Codexis’ biocatalysis technology for key processing steps in the production of four generic drugs under a revised agreement announced last week.
09-Dec-2009 - Sanofi-Aventis, Teva Pharmaceutical Industries and Sinopharm lead the pack in the race to acquire German generics firm Ratiopharm.
07-Dec-2009 - Watson Pharmaceuticals gained US rights to market a generic version of Lipitor (atorvastatin) in 2011 with the acquisition of non-branded drugmaker Arrow Group late last week.
03-Dec-2009 - Pfizer and Protalix have increased the pressure on Genzyme by signing a new accord to commercialise Uplyso (taliglucerase alfa), a potential rival to its Gaucher’s disease treatment Cerezyme, just days...
02-Dec-2009 - Indian API maker Avon Organics’ share price rocketed 10 per cent on the Bombay exchange yesterday after the US launch of a generic herpes treatment by Ranbaxy Laboratories.
01-Dec-2009 - India’s Cipla is in talks with a number of global pharma players, including Pfizer, about potential generics supply deals.
01-Dec-2009 - The Pharma sector’s shift away from blockbusters could result in higher taxes according to PricewaterhouseCoopers (PwC).
24-Nov-2009 - French drugmaker Servier has opened a new €47m manufacturing and R&D facility in Ireland.
23-Nov-2009 - Just weeks after completing its billion dollar Wyeth takeover, US drug giant Pfizer has floated the idea of entering Japan’s $5.8bn (€3.9bn)-a-year generic drugs market in 2011 in a bid...
18-Nov-2009 - The FDA encourages innovation in excipients to develop new drugs or improve approved therapeutics and IPEC is helping to drive acceptance of these novel products, according to BASF.
02-Nov-2009 - Early-stage CDC research suggests that the anti-inflammatory properties of cholesterol-busting statin drugs can help mitigate the impact of flu infection.
29-Oct-2009 - Late last week Ecuador’s government announced plans to sidestep patents on more than 2,000 drugs, enabling them to produced local or imported as “generics”
20-Oct-2009 - Patients want nasal delivery devices that are portable, hygienic and can be used discretely, according to a director at Valois who delivered a talk on the company’s side-actuated product at...
19-Oct-2009 - The EC’s plan to make excipients comply with GMP is “still alive”, according to Cargill which spoke to in-PharmaTechnologist at CPhI about its Zerose erythritol product that it claims can...
19-Oct-2009 - Critical Pharmaceuticals has received a £1.5m ($2.4m) award to develop its hGH nasal spray, the market for which could be sizeable as company’s attempt to differentiate in response to generic...
15-Oct-2009 - ACRO says while a 12-year exclusivity period for innovative drugs is important for R&D, US legislation should include rules on trials for biosimilars
15-Oct-2009 - Packaging group Stralfors says its recent collaboration with Novo Nordisk proves that its service plan is ideal for projects with strict time-to-market requirements.
08-Oct-2009 - We look ahead to CPhI 2009 which takes place in Madrid, Spain next week and will showcase the world’s leading ingredients, contract services, machinery and biotech companies.
08-Oct-2009 - Canadian drugmaker Labopharm says its Italian API maker Gruppo Angelini has resolved all the US FDA concerns about processes used to make a once-a day version of the depression drug...
07-Oct-2009 - Its new microparticle technology licensing deal with Genentech could be worth as much as $200m (€136m) says US delivery specialist SurModics.
07-Oct-2009 - French drug major Sanofi Aventis, Israel's Teva Pharmaceutical Industries and Germany’s Ratiopharm were raided by European Commission (EC) competition officials yesterday as part of an ongoing investigation.
06-Oct-2009 - Despite the government’s “aggressive” promotion of generic drugs, pharmaceutical spending in France will continue to grow, according to new analysis by Business Monitor International (BMI).
06-Oct-2009 - Hospira has acquired the worldwide rights to filgrastim and a Croatian biologics plant from Pliva, increasing its presence in the biogenerics field, and told in-PharmaTechnologist that further expansions are possible.
29-Sep-2009 - The FDA is to establish current good manufacturing practice (cGMP) requirements for combination products to eliminate inconsistencies that could affect product safety and public health.
03-Sep-2009 - Wyeth’s battles to protect the controlled-release (CR) version of its anti-depressant Effexor are a sign of things to come according to a new Espicom report identifying 30 CR drugs likely...